Abstract
Venous thromboembolism (VTE), which includes acute pulmonary embolism (PE) and deep vein thrombosis (DVT), is responsible for 250,000 annual hospitalizations in the United States and is a major cause of morbidity and mortality worldwide. Advancing age is the strongest risk factor for VTE prevalence. Acute PE is the most serious clinical presentation of VTE.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Belohlavek J, Dytrych V, Linhart A. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(2):129–38.
Centers for Disease Control and Prevention. Venous Thromboembolism. 2017.https://www.cdc.gov/ncbddd/dvt/data.html.
Wolf SJ, et al. Prospective validation of wells criteria in the evaluation of patients with suspected pulmonary embolism. Ann Emerg Med. 2004;44(5):503–10.
Investigators P. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA. 1990;263(20):2753–9.
Aujesky D, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041–6.
Dentali F, et al. Pulmonary embolism severity index accurately predicts long-term mortality rate in patients hospitalized for acute pulmonary embolism. J Thromb Haemost. 2013;11(12):2103–10.
Meyer G, Vieillard-Baron A, Planquette B. Recent advances in the management of pulmonary embolism: focus on the critically ill patients. Ann Intensive Care. 2016;6(1):19.
Aujesky D, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J. 2006;27(4):476–81.
Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part II: risk stratification, treatment, and prevention. Circulation. 2003;108(23):2834–8.
Jaff MR, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–830.
Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer. J Am Coll Cardiol. 2017;70(19):2411–20.
Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008;358(10):1037–52.
Sosland RP, Gupta K. Images in cardiovascular medicine: McConnell’s Sign. Circulation. 2008;118(15):e517–8.
Kearon C, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–52.
Dudzinski DM, Piazza G. Multidisciplinary pulmonary embolism response teams. Circulation. 2016;133(1):98–103.
Meyer G, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370(15):1402–11.
Konstantinides SV, et al. Management of pulmonary embolism: an update. J Am Coll Cardiol. 2016;67(8):976–90.
Zamorano JL, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(43):3033–73.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Mieszczanska, H.Z., Cameron, S.J. (2018). Pulmonary Embolism. In: Mieszczanska, H., Budzikowski, A. (eds) Cardiology Consult Manual. Springer, Cham. https://doi.org/10.1007/978-3-319-89725-7_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-89725-7_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89724-0
Online ISBN: 978-3-319-89725-7
eBook Packages: MedicineMedicine (R0)